Home » Topics » Briefs » Other news to note

Other news to note
RSS

Dainippon Sumitomo and Sepracor complete tender offer

Oct. 16, 2009

BioAlliance granted approval in France to initiate phase I clinical trial of fentanyl

Oct. 14, 2009

RXi Pharmaceuticals presents preclinical results from animal studies of sd-rxRNA

Oct. 13, 2009

AC Immune to utilize Bayer's florbetaben in phase I trial of AD vaccine ACI-24

Oct. 13, 2009

GPC Biotech provides update on merger with Agennix

Oct. 13, 2009

YM BioSciences to acquire all issued Cytopia shares and options

Oct. 8, 2009

Physiology or Medicine 2009 Nobel Prize awarded to U.S. scientists for work on telomeres

Oct. 7, 2009

DOR BioPharma changes its name to Soligenix

Oct. 5, 2009

Raptor Pharmaceuticals and TorreyPines Therapeutics merge

Oct. 1, 2009

Stockholders from Raptor Pharmaceuticals and TorreyPines Therapeutics approve merger

Sep. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...